Eco-conscious AQbD-guided stability-indicating RP-UPLC method for analysing Tovorafenib in bulk and dosage forms

Vanga Mohan Goud1, Sarad Pawar Naik Bukke2, Praveen Kumar Kusuma3

  • 1Department of Pharmaceutical Analysis, Joginpally BR Pharmacy College, Telangana, 500075, Hyderabad, India.

Scientific Reports
|December 5, 2025
PubMed

Insights

A new, eco-friendly liquid chromatography method quantifies Tovorafenib, an important drug for pediatric low-grade glioma. This validated method ensures accurate drug analysis for quality control and environmental sustainability.

Area of Science:

  • Analytical Chemistry
  • Pharmaceutical Science
  • Green Chemistry

Background:

  • Tovorafenib, a type II RAF inhibitor, is FDA-approved for pediatric low-grade glioma with specific BRAF alterations.
  • It offers advantages over type I inhibitors due to CNS penetration and lack of paradoxical MAPK activation.

Purpose of the Study:

  • To develop and validate a rapid, robust, and green reversed-phase ultra-performance liquid chromatography (RP-UPLC) method for Tovorafenib quantification.
  • To align method development with ICH Q14 and validation with ICH Q2(R1) guidelines, incorporating Analytical Quality by Design (AQbD) and green analytical chemistry principles.

Main Methods:

  • Utilized a Waters Acquity UPLC BEH C18 column with a specific mobile phase (water:methanol, 62:38 v/v) and PDA detection at 292 nm.
  • Employed ICH Q14 for development and ICH Q2(R1) for validation, including linearity, reproducibility, and forced degradation studies.
  • Assessed environmental impact using various green chemistry metrics (e.g., ComplexMoGAPI, AGREE, RAPI).

Main Results:

  • The method demonstrated excellent linearity (r² = 0.9997) and reproducibility (low %RSD).
  • Tovorafenib showed stability under most forced degradation conditions, with sensitivity to acid hydrolysis.
  • Favorable eco-scores were obtained, indicating a sustainable analytical approach.

Conclusions:

  • The validated RP-UPLC method provides a reliable, sensitive, and sustainable means for Tovorafenib analysis.
  • This approach supports efficient pharmaceutical quality control while adhering to environmental sustainability principles.
  • The study highlights the successful integration of AQbD and green chemistry in analytical method development.

Related Concept Videos

Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
164
Measurement of Bioavailability: Pharmacodynamic Methods01:20

Measurement of Bioavailability: Pharmacodynamic Methods

Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
217
Measurement of Bioavailability: Pharmacokinetic Methods01:30

Measurement of Bioavailability: Pharmacokinetic Methods

Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
238
Drug Product Performance: In Vitro–In Vivo Correlation01:20

Drug Product Performance: In Vitro–In Vivo Correlation

In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while...
211
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
186
Methods for Studying Drug Absorption: In vitro01:16

Methods for Studying Drug Absorption: In vitro

In vitro experiments are crucial for understanding the transport and absorption of drugs through biological materials. These studies employ varied methods such as the diffusion cell method, the everted sac technique, and the everted ring technique.
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
550